Scientific Reports (May 2022)

Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein

  • Emi E. Nakayama,
  • Ritsuko Kubota-Koketsu,
  • Tadahiro Sasaki,
  • Keita Suzuki,
  • Kazuko Uno,
  • Jun Shimizu,
  • Toru Okamoto,
  • Hisatake Matsumoto,
  • Hiroshi Matsuura,
  • Shoji Hashimoto,
  • Toshio Tanaka,
  • Hiromasa Harada,
  • Masafumi Tomita,
  • Mitsunori Kaneko,
  • Kazuyuki Yoshizaki,
  • Tatsuo Shioda

DOI
https://doi.org/10.1038/s41598-022-12252-y
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Abstract A cytokine storm induces acute respiratory distress syndrome, the main cause of death in coronavirus disease 2019 (COVID-19) patients. However, the detailed mechanisms of cytokine induction due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain unclear. To examine the cytokine production in COVID-19, we mimicked the disease in SARS-CoV-2-infected alveoli by adding the lysate of SARS-CoV-2-infected cells to cultured macrophages or induced pluripotent stem cell-derived myeloid cells. The cells secreted interleukin (IL)-6 after the addition of SARS-CoV-2-infected cell lysate. Screening of 25 SARS-CoV-2 protein-expressing plasmids revealed that the N protein-coding plasmid alone induced IL-6 production. The addition of anti-N antibody further enhanced IL-6 production, but the F(ab’)2 fragment did not. Sera from COVID-19 patients also enhanced IL-6 production, and sera from patients with severer disease induced higher levels of IL-6. These results suggest that anti-N antibody promotes IL-6 production in SARS-CoV-2-infected alveoli, leading to the cytokine storm of COVID-19.